Page last updated: 2024-08-23

amikacin and Neointima

amikacin has been researched along with Neointima in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fairaq, A; Osman, I; Pichavaram, P; Segar, L; Shawky, NM	1

Other Studies

1 other study(ies) available for amikacin and Neointima

Article	Year
AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia. Pharmacological research, 2017, Volume: 119 Topics: AMP-Activated Protein Kinases; Animals; Arteries; Cell Line; Cell Proliferation; Humans; Male; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Neointima; Piperidines; Platelet-Derived Growth Factor; Receptors, Adiponectin; Signal Transduction; TOR Serine-Threonine Kinases	2017

Article

Year

AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.

Pharmacological research, 2017, Volume: 119

Topics: AMP-Activated Protein Kinases; Animals; Arteries; Cell Line; Cell Proliferation; Humans; Male; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Neointima; Piperidines; Platelet-Derived Growth Factor; Receptors, Adiponectin; Signal Transduction; TOR Serine-Threonine Kinases

2017